XoWiki mobile view
 

 

Active Studies

Expression of stress markers in MSM living with HIV receiving contingency management for methamphetamine use disorder (a.k.a "EXPRESS+")

INTEGRA: A Vanguard Study of Health Service Delivery in a Mobile Health Delivery Unit to Link Persons who Inject Drugs to Integrated Care and Prevention for Addiction, HIV, HCV and Primary Care.

A phase 1, randomized, open-label clinical trial to evaluate the safety and immunogenicity of HIV trimer mRNA vaccines in healthy, HIV-uninfected adult participants.

Inflammation in Methamphetamine and STIs

Phase 1 safety-interaction study of mirtazapine for the treatment of methamphetamine use disorder

A Phase 3, Double-Blind, Multicenter, Randomized Study to Evaluate the Efficacy and Safety of Subcutaneous Twice Yearly Long-Acting Lenacapvir for HIV Pre-Exposure Prophylaxis (PrEP) in Cisgender Men, Transgender Women, Transgender Men, and Gender Non-binary people 18 Years of Age or Older who Have Sex with Male Partners and are at Risk of HIV Infection.